ABEONA THERAPEUTICS INC. Inventory, Raw Materials, Gross
ABEONA THERAPEUTICS INC. (ABEO) had Inventory, Raw Materials, Gross of $5.28 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:InventoryRawMaterials · last filed 2026-08-13
- 2026-06-30: Inventory, Raw Materials, Gross $5.28M.
- 2026-03-31: Inventory, Raw Materials, Gross $5.50M.
- 2025-12-31: Inventory, Raw Materials, Gross $5.49M.
| Period end | Inventory, Raw Materials, Gross |
|---|---|
| 2026-06-30 | $5.28M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $5.50M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $5.49M 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |